These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Hammerhead ribozymes targeted to the FBN1 mRNA can discriminate a single base mismatch between ribozyme and target. Phylactou LA; Tsipouras P; Kilpatrick MW Biochem Biophys Res Commun; 1998 Aug; 249(3):804-10. PubMed ID: 9731217 [TBL] [Abstract][Full Text] [Related]
5. Differential activity of trans-acting hammerhead ribozymes targeted to beta amyloid peptide precursor mRNA by altering the symmetry of helices I and III. Denman RB; Smedman M; Kung L Arch Biochem Biophys; 1995 Oct; 323(1):71-8. PubMed ID: 7487076 [TBL] [Abstract][Full Text] [Related]
6. The effect of structure in a long target RNA on ribozyme cleavage efficiency. Campbell TB; McDonald CK; Hagen M Nucleic Acids Res; 1997 Dec; 25(24):4985-93. PubMed ID: 9396806 [TBL] [Abstract][Full Text] [Related]
7. Oligonucleotide facilitators enable a hammerhead ribozyme to cleave long RNA substrates with multiple-turnover activity. Jankowsky E; Schwenzer B Eur J Biochem; 1998 May; 254(1):129-34. PubMed ID: 9652405 [TBL] [Abstract][Full Text] [Related]
9. Reversal of the in vivo metastatic phenotype of human tumor cells by an anti-CAPL (mts1) ribozyme. Maelandsmo GM; Hovig E; Skrede M; Engebraaten O; Flørenes VA; Myklebost O; Grigorian M; Lukanidin E; Scanlon KJ; Fodstad O Cancer Res; 1996 Dec; 56(23):5490-8. PubMed ID: 8968106 [TBL] [Abstract][Full Text] [Related]
10. A structural analysis of in vitro catalytic activities of hammerhead ribozymes. Shao Y; Wu S; Chan CY; Klapper JR; Schneider E; Ding Y BMC Bioinformatics; 2007 Nov; 8():469. PubMed ID: 18053134 [TBL] [Abstract][Full Text] [Related]
11. Intermolecular cleavage by the newt ribozyme. Marusic L; Luzi E; Barsacchi G; Eckstein F Eur J Biochem; 1997 Jul; 247(1):396-401. PubMed ID: 9249052 [TBL] [Abstract][Full Text] [Related]
12. Hammerhead ribozymes designed to cleave all human rod opsin mRNAs which cause autosomal dominant retinitis pigmentosa. Sullivan JM; Pietras KM; Shin BJ; Misasi JN Mol Vis; 2002 Apr; 8():102-13. PubMed ID: 11961505 [TBL] [Abstract][Full Text] [Related]
13. Efficient improvement of hammerhead ribozyme mediated cleavage of long substrates by oligonucleotide facilitators. Jankowsky E; Schwenzer B Biochemistry; 1996 Dec; 35(48):15313-21. PubMed ID: 8952482 [TBL] [Abstract][Full Text] [Related]
14. Determination of hammerhead ribozyme kinetic constants at high molar ratio ribozyme-substrate. Grassi G; Grassi M; Kuhn A; Kandolf R J Math Biol; 2002 Sep; 45(3):261-77. PubMed ID: 12373347 [TBL] [Abstract][Full Text] [Related]
15. Novel cleavage of a hammerhead ribozyme targeted to beta-amyloid peptide precursor mRNA. Denman R; Miller DL Arch Biochem Biophys; 1993 Sep; 305(2):392-400. PubMed ID: 8373177 [TBL] [Abstract][Full Text] [Related]
16. Ribozyme-targeted destruction of RNA associated with autosomal-dominant retinitis pigmentosa. Drenser KA; Timmers AM; Hauswirth WW; Lewin AS Invest Ophthalmol Vis Sci; 1998 Apr; 39(5):681-9. PubMed ID: 9538873 [TBL] [Abstract][Full Text] [Related]
17. Design and specificity of hammerhead ribozymes against calretinin mRNA. Ellis J; Rogers J Nucleic Acids Res; 1993 Nov; 21(22):5171-8. PubMed ID: 8255773 [TBL] [Abstract][Full Text] [Related]
18. Selective cleavage of bcr-abl chimeric RNAs by a ribozyme targeted to non-contiguous sequences. Pachuk CJ; Yoon K; Moelling K; Coney LR Nucleic Acids Res; 1994 Feb; 22(3):301-7. PubMed ID: 8127665 [TBL] [Abstract][Full Text] [Related]
19. Selection of hammerhead ribozymes for optimum cleavage of interleukin 6 mRNA. Hendrix C; Anné J; Joris B; Van Aerschot A; Herdewijn P Biochem J; 1996 Mar; 314 ( Pt 2)(Pt 2):655-61. PubMed ID: 8670082 [TBL] [Abstract][Full Text] [Related]